Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;51(8):1462-1475.
doi: 10.1007/s00134-025-08026-5. Epub 2025 Jul 14.

Source control in bloodstream infections in patients with sepsis, septic shock, or requiring ICU admission: a scoping review with recommendations for standardizing research

Affiliations

Source control in bloodstream infections in patients with sepsis, septic shock, or requiring ICU admission: a scoping review with recommendations for standardizing research

Alexis Tabah et al. Intensive Care Med. 2025 Aug.

Abstract

Background: Bloodstream infections (BSI) account for 15% of intensive care unit (ICU) infections, often causing sepsis with mortality rates up to 50%. Source control (SC), encompassing interventions to reduce bacterial or fungal load and prevent infection spread, is a critical yet under-investigated component of management.

Objectives: This scoping review examines SC definitions, interventions, timing, adequacy, and outcomes in BSI literature in patients with sepsis, septic shock, or ICU admission, and offers a proposal for standardized reporting.

Methods: We searched Medline, EMBASE, and Cochrane Library for studies on adult BSI addressing SC in populations with ≥ 50% ICU admission, ≥ 75% sepsis, or ≥ 25% septic shock, extracted and reported data following established guidance.

Results: From 2193 abstracts, 77 studies were included. SC was a primary objective in 21%, with others reporting it alongside other objectives. Candidemia (47%) and catheter removal (60%) studies were predominant, with 34% evaluating catheter removal regardless of BSI source. SC definitions varied from no definition (8%), minimal (7%), concise (17%), comprehensive (9%) definitions and catheter removal (60%). Forty-seven % reported proportions receiving SC for the entire cohort rather than those requiring SC. Timing was reported by 68%, with inconsistent definitions. SC adequacy was assessed by 3%. SC improved outcomes in 65%, with no reported harm.

Conclusion: SC research in severe BSI is limited by inconsistent definitions, poor SC efficacy assessments, and overrepresentation of catheter-source BSI and candidemia. Standardized reporting is essential to enhance evidence quality and optimize BSI management in critically ill patients.

Keywords: Bloodstream infection; Sepsis; Source; Source control.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflicts of interest: Alexis Tabah has nothing to disclose, Jan De Waele has consulted for Biomerieux, Menarini, MSD, Pfizer, Roche Diagnostics, ThermoFisher and Viatris (fees and honoraria paid to institution), Nathalie Ssi Yan Kai has nothing to disclose, Abdullah Tarik Aslan has nothing to disclose, Niccolo Buetti has nothing to disclose, Jean-François Timsit reported advisory boards participation for Merck, Gilead, Beckton-Dickinson, Pfizer, Menarini, Advanz, Paratek, research grants from Merck and Pfizer, Emma Ballard has nothing to disclose, Lars Eriksson, Kevin Laupland reported grants to his research unit from Pfizer and Merck, consulting fees from Menarini, Merck, Biomerieux, Roche diagnostics advanz, all outside of the submitted work, lecture honoraria from Pfizer, Merck, Biomerieux, Shionogi, advanz, Gilead mundipharma outside of the submitted work, and support for attending meetings from Tillots. Jeffrey Lipman has nothing to disclose. Jan De Waele is supported by a Sr Clinical Research Grant from the Research Foundation Flanders (FWO, Ref. 1881020N). Ethical approval: Since our scoping review did not involve human or animal studies, no ethics committee approval was required, and the study adheres to the ethical standards outlined in the 1964 Declaration of Helsinki and its later amendments.

Figures

Fig. 1
Fig. 1
Measures of time to source control. Percentages calculated with 52 studies that assessed timing as a denominator. The figure displays the two components of time-to-source-control measurement: the various starting points ("time 0″) used by studies on the left, and whether studies defined the endpoint on the right. The lower part of the figure shows the proportion of studies using each definition, illustrating the substantial heterogeneity in how timing is measured across the literature. BC Blood Culture, ED Emergency department. Time to source control equals the interval between "time zero" and "time of SC”

Similar articles

References

    1. Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT et al (2023) Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med 49(2):178–190. 10.1007/s00134-022-06944-2 - PMC - PubMed
    1. Lee SY, Park MH, Oh DK, Lim CM, Korean Sepsis Alliance I (2024) Polymicrobial bloodstream infections per se do not increase mortality compared to monomicrobial bloodstream infections in sepsis patients: a Korean nationwide sepsis cohort study. BMC Infect Dis. 10.1186/s12879-024-09130-5 - PMC - PubMed
    1. Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC et al (2020) Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323(15):1478–1487. 10.1001/jama.2020.2717 - PMC - PubMed
    1. Stewart AG, Laupland KB, Tabah A (2023) Central line associated and primary bloodstream infections. Curr Opin Crit Care 29(5):423–429. 10.1097/MCC.0000000000001082 - PubMed
    1. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47(11):1181–1247. 10.1007/s00134-021-06506-y - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources